Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
14.4M
-
Shares change
-
+2.29M
-
Total reported value, excl. options
-
$41.2M
-
Value change
-
+$6.45M
-
Put/Call ratio
-
45.88
-
Number of buys
-
46
-
Number of sells
-
-18
-
Price
-
$2.86
Significant Holders of Humacyte, Inc. - COM (HUMA) as of Q2 2023
84 filings reported holding HUMA - Humacyte, Inc. - COM as of Q2 2023.
Humacyte, Inc. - COM (HUMA) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.4M shares
.
Largest 10 shareholders include BlackRock Inc. (4.3M shares), VANGUARD GROUP INC (2.97M shares), GEODE CAPITAL MANAGEMENT, LLC (1.1M shares), STATE STREET CORP (1.04M shares), Prescott General Partners LLC (568K shares), NORTHERN TRUST CORP (500K shares), DAVIDSON KEMPNER CAPITAL MANAGEMENT LP (450K shares), LUMINUS MANAGEMENT LLC (400K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (400K shares), and NORGES BANK (374K shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.